Day: June 27, 2025

This article explains how FDA investigators evaluate GMP compliance in real inspections, revealing why Form 483 observations recur. It breaks down inspection logic, common control gaps, and practical readiness steps that help quality, manufacturing, and regulatory teams reduce inspection risk.